Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Cellectis (NASDAQ:CLLS) through any online brokerage.
Other companies in Cellectis’s space includes: Cabaletta Bio Inc (NASDAQ:CABA), Monopar Therapeutics Inc (NASDAQ:MNPR), Immuneering Corp (NASDAQ:IMRX), DiaMedica Therapeutics Inc (NASDAQ:DMAC) and Palisade Bio Inc (NASDAQ:PALI).
Cellectis has a consensus price target of $9.80.
The stock price for Cellectis (NASDAQ: CLLS) is $3.41 last updated April 2, 2026 at 4:02 PM EDT.
There are no upcoming dividends for Cellectis.
Cellectis does not have any upcoming earnings scheduled.
There is no upcoming split for Cellectis.
Cellectis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.